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http://www.biomedcentral.com/1471-2091/13/20RESEARCH ARTICLE Open AccessStructure-function analysis indicates that
sumoylation modulates DNA-binding
activity of STAT1
Juha Grönholm1†, Sari Vanhatupa1†, Daniela Ungureanu1†, Jouni Väliaho1, Tuomo Laitinen2, Jarkko Valjakka1
and Olli Silvennoinen1,3*Abstract
Background: STAT1 is an essential transcription factor for interferon-γ-mediated gene responses. A distinct
sumoylation consensus site (ψKxE) 702IKTE705 is localized in the C-terminal region of STAT1, where Lys703 is a
target for PIAS-induced SUMO modification. Several studies indicate that sumoylation has an inhibitory role on
STAT1-mediated gene expression but the molecular mechanisms are not fully understood.
Results: Here, we have performed a structural and functional analysis of sumoylation in STAT1. We show that
deconjugation of SUMO by SENP1 enhances the transcriptional activity of STAT1, confirming a negative regulatory
effect of sumoylation on STAT1 activity. Inspection of molecular model indicated that consensus site is well
exposed to SUMO-conjugation in STAT1 homodimer and that the conjugated SUMO moiety is directed towards
DNA, thus able to form a sterical hindrance affecting promoter binding of dimeric STAT1. In addition,
oligoprecipitation experiments indicated that sumoylation deficient STAT1 E705Q mutant has higher DNA-binding
activity on STAT1 responsive gene promoters than wild-type STAT1. Furthermore, sumoylation deficient STAT1
E705Q mutant displayed enhanced histone H4 acetylation on interferon-γ-responsive promoter compared to
wild-type STAT1.
Conclusions: Our results suggest that sumoylation participates in regulation of STAT1 responses by modulating
DNA-binding properties of STAT1.
Keywords: Signal transduction, Transcription factors, Sumoylation, Signal transducers and activators of transcription
(STATs), InterferonBackground
STAT1 (Signal transducer and activator of transcription
1) is the founder member of the STAT family of tran-
scription factors and plays a critical role in interferon
(IFN) regulated gene responses. IFN-γ activates STAT1
through Janus kinase (JAK)-mediated phosphorylation of
Tyr701. Activated STAT1 homodimerizes and translo-
cates to the nucleus where it binds to DNA and initiates
transcription of IFN-γ-regulated genes [1,2]. The X-ray* Correspondence: olli.silvennoinen@uta.fi
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distribution, and reproduction in any mediumstructure (1bf5.pdb) of the DNA-bound STAT1 dimer
shows a contiguous C-shaped clamp around DNA, that is
mediated by specific interactions between the SH2 domain
and the tyrosine (Tyr701) phosphorylated C-terminal tail
segment (residues 700–708) of the monomers [3].
Small ubiquitin-like modifier (SUMO) proteins belong
to the family of ubiquitin-like protein modifiers, collect-
ively termed Ubls, that are covalently attached to sub-
strate proteins by a cascade of enzymatic reactions [4].
The conjugation is regulated by distinct SUMO specific
enzymes such as E1 activating enzyme Aos1/Uba2 and
the E2 conjugase Ubc9. The protein inhibitor of acti-
vated STAT (PIAS) family of proteins, PIAS1, PIAS3,
PIASx and PIASy have been shown to function as E3-
type ligases to promote SUMO conjugation to the targettral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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STAT1-mediated transcription through interaction with
the dimerized STAT1 and by inhibiting STAT1 DNA-
binding [8,9]. Interestingly, PIAS proteins have also
been shown to promote sumoylation of STAT1 at single
Lys703 amino acid residue within the SUMO consensus
sequence (ψKxE, where ψ indicates large hydrophobic
amino acid and x refers to any amino acid) 702IKTE705
in the C-terminal region of STAT1 [10,11]. Furthermore,
it has been shown that mitogen activated protein kinase
(MAPK)-induced phosphorylation of Ser727 in STAT1
promotes interaction of STAT1 with PIAS1 and leads
to enhanced STAT1 sumoylation [12].
Several studies suggest that sumoylation has a negative
effect on STAT1-mediated gene responses [11,13,14].
Sumoylation site Lys703 is in a close proximity to
Tyr701 that is required for STAT1 activation, and
sumoylation has been shown to directly inhibit STAT1
Tyr701 phosphorylation [15-17]. Sumoylation has also
been shown to prevent condensation of STAT1 oligo-
mers in the nuclear paracrystals, and thereby increase
the solubility of STAT1 and promote its dephosphoryla-
tion [17]. Recently, it was discovered that in addition to
human STAT1, also murine STAT5 and Drosophila
Stat92E are regulated through SUMO conjugation,
confirming that sumoylation has an evolutionary con-
served role in regulation of the cytokine signaling [18,19].
This study was aimed to investigate the mechanism by
which sumoylation regulates STAT1 activity. Inspection
of molecular model indicates that SUMO consensus site
is well exposed in STAT1 dimer, and it is accessible for
propitious interactions with regulatory proteins. The
constructed molecular model of SUMO-1 conjugated
STAT1 dimer further suggested that SUMO-1 moiety is
oriented towards DNA, thus able to affect the DNA-
binding properties of STAT1 with its presence. The
molecular model was supported by experimental evi-
dence, and oligoprecipitation experiments indicated that
sumoylation deficient STAT1 E705Q mutant display
higher DNA-binding activity on STAT1 target gene pro-
moters when compared to STAT1 wild-type (WT). Fur-
thermore, sumoylation deficient STAT1 mutant showed
enhanced histone H4 acetylation at the Gbp-1 promoter.
Methods
Plasmids
STAT1 WT-HA, STAT1 WT-Flag, STAT1 K703R-HA,
STAT1 E705A-HA and STAT1 Y701F plasmids were
previously described [11-13]. STAT1 E705Q mutation
was created with site directed polymerase chain reac-
tion (PCR) mutagenesis using primers: 5’-GGAAC
TGGATATATCAAGACTCAGTTGATTTCTGTGTC-3’
and 5’-GACACAGAAATCAACTGAGTCTTGATATA
TCCAGTTCC-3’.pSG5-SUMO-1-His was provided by Dr. A. Dejean
[20]. The GAS-luciferase construct contains the IFN-γ
regulated GAS element [21]. Flag-tagged SENP1 and
SENP1 C603S were previously described [22].
Cell culture
Human HeLa cells and monkey Cos-7 cells were cul-
tured in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS)
(Gibco), 100 U/ml penicillin and 50 mg/ml strepto-
mycin. Human fibrosarcoma U3A cells (kindly provided
by Dr. I. Kerr) were cultured in DMEM supplemented
with 10% Cosmic calf serum (CCS) (HyClone, Logan,
UT) and 100 U/ml penicillin and 50 mg/ml strepto-
mycin. Stable U3A-STAT1 WT-HA and U3A-STAT1
K703R-HA clones were previously described [11,13].
Reporter gene assays
Approximately 0.2 × 106 HeLa cells were plated on to
24-well plates and transfected with 0.25 μg CMV-β-
galactosidase reporter plasmid as an internal transfection
efficiency control and 0.25 μg GAS-luciferase construct
together with empty pcDNA3.1 vector as a control or
with increasing amount of SENP1-Flag or SENP1
C603S-Flag. After 36 hours the cells were serum starved
over night with 0.5% FBS in DMEM, following stimula-
tion with 100 ng/ml human IFN-γ (Immugenex, Los
Angeles, CA) for additional 6 hours and lysed in Pro-
mega’s reporter lysis buffer according to the manufac-
turer’s instructions. Luciferase activity was measured
using Luminoscan Ascent (ThermoElectron Corpor-
ation, Finland) and normalized against β-galactosidase
activity of the lysates.
Immunoprecipitation, co-immunoprecipitation and
Immunoblotting
Total amount of 3 × 106 Cos-7 cells were transfected
with 2 μg of STAT1-WT, 1 μg of SUMO-1, together
with 2 μg of SENP1 or 2 μg of SENP1 C603S mutant.
The cells were lysed in Triton X lysis buffer (50 mM
Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 50 mM
NaF, 10% glycerol, 1% Triton X-100) supplemented with
protease inhibitors including 10 mM NEM (Sigma Aldrich,
St. Louis, MO). The lysates were incubated with anti-
STAT1 antibody (monoclonal anti-STAT1 N-terminus,
Transduction Laboratories, BD Biosciences, Franklin
Lakes, NJ) and the immunocomplex was washed and
subjected to SDS-PAGE electrophoresis. STAT1 and
sumoylated STAT1 protein levels were determined by
using anti-STAT1 (Transduction Laboratories) and anti-
SUMO-1 (Zymed) antibodies. SENP1 protein levels from
the whole cell lysates were determined by immunoblot-
ting with anti-Flag antibody (Sigma-Aldrich, St Louis,
MO). For co-immunoprecipitation experiments 1.6 × 106
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STAT1-HA and 3 μg of STAT1-Flag with or without
4 μg of SUMO-1-His using L-PEI transfection reagent as
described [23]. After 48 hours cells were lysed in buffer
containing 20 mM HEPES pH 8.0, 100 mM NaCl, 1%
Triton X-100, 10% glycerol, 50 mM NaF and 1mM
EDTA supplemented with 10 mM NEM and protease
inhibitors. Equal amounts of whole cell lysates were
incubated for 3 hours in rotator at 4°C in the presence
of 20 μl of anti-Flag M2 agarose beads (Sigma Aldrich,
St. Louis, MO). The beads were washed 3 times with the
lysis buffer and anti-Flag immunoprecipitated proteins
were released from the beads by incubating them in
the presence of Flag-peptide (F3290, Sigma Aldrich,
St. Louis, MO) for 30 min at 4°C. Proteins were sepa-
rated by SDS-PAGE and STAT1 was detected by
immunoblotting using anti-HA antibody (clone 16B12,
Covance, Princeton, NY). STAT1 and SENP1 protein
levels from luciferase assay samples were analysed by im-
munoblotting using anti-STAT1 and anti-Flag antibodies,
respectively.
Oligoprecipitation
Total amount of 5 × 105 U3A cells were transfected with
6 μg of STAT1 WT-HA or STAT1 E705Q-HA or STAT1
Y701F-HA mutants together with 4 μg of SUMO-1-His
using L-PEI transfection reagent. After 48 hour incuba-
tion at 37°C cells were either left unstimulated or stimu-
lated with 100 ng/ml of human IFN-γ (Immugenex, Los
Angeles, CA) for total of 1 hour and by osmotic shock
(0.3 M sorbitol) for 15 minutes. The cells were lysed in
lysis buffer (0.5% Triton X-100, 100 mM Tris–HCl pH
7.5, 0.2 mM EDTA, 300 mM NaCl, 1 mM DTT, 10% gly-
cerol, 1 mM NaF) supplemented with protease inhibi-
tors. The lysates were diluted fourfold with dilution
buffer lacking NaCl (0.1% Triton X-100, 100 mM
Tris–HCl pH 7.5, 0.2 mM EDTA, 1 mM DTT, 1.0% gly-
cerol, 1 mM NaF supplemented with protease inhibitors).
For the binding assay, a biotinylated oligonucleo-
tide containing the GAS from the human Gbp-1 gene
(5’-GGATCCTACTTTCAGTTTCATATTACTCTAAAT-3’)
or STAT1 binding site from human Irf-1 gene (5’-GGATCC
CAACAGCTTGATTTCCCCGAAATGACGGCA-3’) pro-
moter was annealed and 3 nmols of biotinylated oligo-
nucleotide duplex were rotated for 2 hours at 4°C with
Neutravidin agarose to form GAS-agarose affinity beads.
Diluted cell extracts were precleared with Neutravidin
beads and then incubated with GAS-agarose affinity
beads for 2 hours in rotator at 4°C. The beads were then
washed four times with buffer containing 0,2% Triton X-
100, 10 mM HEPES pH 7.9, 2 mM EDTA, 1 mM EGTA,
150 mM KCl, 10% glycerol and 1 mM NaF. GAS-agarose
affinity bead-bound proteins were subjected to SDS-
PAGE and detected by immunoblotting with phospho-tyrosine (Tyr701)-specific STAT1 antibody (Cell Signal-
ing). The Western blot membranes were stripped and
reprobed with anti-HA antibody (Covance, Princeton,
NY) to detect total amount of DNA-bound STAT1.
Detected bands were quantified by using ImageJ image
analysis software and analyzed after background
subtraction.Chromatin immunoprecipitation
Stable U3A-STAT1 WT-HA and U3A-STAT1 K703R-
HA clones were starved and left unstimulated or stimu-
lated with IFN-γ for 1h. Chromatin immunoprecipitation
(ChIP) was performed as previously described [24] using
anti-acetyl-histone H4 antibody (Upstate Biotech) or as a
control, anti-IgG antibody (Santa Cruz Biotechnology).
DNA was analyzed for human Gbp-1 promoter by
quantitative-RT-PCR with the following primers: 5’-
AGCTTCTGGTTGAGAAATCTTT-3’ and 5’-CCCTG
GACTAATATTTCACTG-3’. Quantitative-PCR was done
using SYBR green I kit (Qiagen) according to manufac-
turer’s instructions. The values from ChIP assays were
normalized to the total input DNA.Molecular modeling
A 3D-structure of STAT1 dimer with DNA has been
built using crystal structure of tyrosine phosphorylated
STAT1-DNA complex (PDB code:1BF5) [3]. The
molecular geometry of the loop 684–699 in the SH2
domain was calculated using the program Sybyl with
Amber 7 FF99 force field parameters. The initial model
for the loop region was constructed using the crossover
loop structure from the SUMO-1-TDG (PDB code:1-
wyw) [25] as a template. First, during the energy and
geometry minimization for the loop all hydrogen atoms
and non-constraints were included in the protocol.
Second, during the molecular dynamic refinement
the constraints were on for outer part of the loop in the
SH2 domain. After the loop modeling we used the
deposited coordinates of SUMO-1 (PDB code:1wyw)
[25] in our model. The SUMO-1 was set nearby the
constructed loop 684–699 so that its C-terminal residue
(Gly97) is in the vicinity of the Lys703 of the STAT1
and the loop can form a new β-strand to an existing
antiparallel β- sheet structure in the SUMO-1. The loop
684–699 was also modeled with InsightII (2005, Accelrys
Inc. InsightII - molecular modeling program. http://www.
accelrys.comomain; 1wyw.pdb). The entire structure was
then subjected to energy minimization using the mo-
lecular mechanics force field CVFF (consistent valence
force field) and the steepest descent algorithm imple-
mented under Insight II Discover program. During the
minimization, the DNA and the atoms of the STAT1
residues 136–686 and 700–710 were fixed.
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SENP1 deconjugates SUMO-1 from STAT1 and enhances
STAT1-mediated gene expression
The covalent modification of proteins by SUMO-1 is
known to be a reversible process [22]. We wanted to
confirm the effect of sumoylation of STAT1 in cells by
analyzing whether STAT1 is a substrate for SUMO pro-
tease SENP1. For this, STAT1, SUMO-1 and SENP1-
Flag or catalytically inactive SENP1 C603S-Flag were
transfected into Cos-7 cells and equal amounts of pro-
tein was immunoprecipitated with anti-STAT1 antibody
and immunoblotted with anti-STAT1 and anti-SUMO-1
antibodies. As shown in Figure 1A, co-transfection ofFigure 1 Sumoylated STAT1 is target for SENP1-mediated desumoyla
transiently transfected with expression vectors containing STAT1-HA, SUMO
After 36 hours the cells were lysed and total cell lysates were immunoprec
SUMO-1 and anti-STAT1 antibodies. SENP1 protein levels were verified by i
augments STAT1 transcriptional activity in cultured cells. HeLa cells were tr
tagged WT SENP1 or SENP1 C603S together with GAS-luciferase reporter an
After 36 hours cells were starved over night and stimulated with 100 ng/m
normalized against β-galactosidase values. SENP1 and endogenous STAT1
using anti-Flag and anti-STAT1 antibodies, respectively. Error bars indicate S
immunoprecipitation.SENP1 WT completely abolished the slower migrating
STAT1-SUMO-1 band indicating that sumoylation of
STAT1 is reversible and SENP1 can act as a SUMO-
specific isopeptidase for STAT1.
The identification of STAT1 as a substrate for SENP1
prompted us to investigate whether SENP1-mediated
desumoylation affects the transcriptional activity of
STAT1. For this purpose, we analysed the activity of
STAT1-responsive GAS-luciferace reporter in HeLa cells
transfected with different concentrations of SENP1 WT
or SENP1 C603S mutant. As shown in Figure 1B, over-
expression of SENP1 significantly increased the tran-
scriptional activity of endogenous STAT1. In contrast,tion. (A) SENP1 desumoylates STAT1 in Cos-7 cells. Cos-7 cells were
-1-His and Flag-tagged SENP1 or SENP1 C603S mutant as indicated.
ipitated with anti-STAT1 antibody and immunoblotted with anti-
mmunoblotting with anti-Flag antibody. (B) SENP1 overexpression
ansfected with either empty vector or with increasing amount of Flag-
d CMV-β-galactosidase reporter for normalizing transfection efficiency.
l of human IFN-γ for 6 hours prior to cell lysis. Luciferase values were
expression levels were verified from the lysates by immunoblotting
D from 3 independent transfections. IB: immunoblot, IP:
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resulted in a dose-dependent decrease in GAS-luciferase
activity, most probably by blocking the interaction of
endogenous SENP1 with STAT1, leading to increased
level of SUMO-modified STAT1 in the cells. This effect
is also seen in Figure 1A, where STAT1 sumoylation
is significantly increased when SENP1 C603S is co-
transfected into the Cos-7 cells. Collectively, these
results indicate that desumoylation of STAT1 enhances
its transcriptional activity. These results are in line with
previously reported results that sumoylation deficient
STAT1 mutants display higher transcriptional activity at
STAT1 target gene promoters [13,14].
Molecular model of the SUMO conjugated STAT1 dimer
IFN-γ-induced activation of STAT1 transcription factor
requires phosphorylation of Tyr701 leading to its rapid
homodimerization followed by translocation to the
nucleus and binding to the target gene promoters [3].
To obtain further insight on the mechanisms and conse-
quences of SUMO conjugation to STAT1, we modeled
the SUMO moiety and analysed its orientation in STAT1
dimer using information from the published structure of
Tyr701 phosphorylated STAT1 homodimer bound to
DNA [3]. The interaction between STAT1 monomers is
formed between SH2 domain and phosphorylated tyro-
sine 701 of an adjacent monomer, so that the phosphate
group is recognized by the strictly conserved Arg602
residue that rises up from the interior of the SH2
domain. Analysis of the SUMO conjugation site
(Figure 2A) demonstrated that the side chains of Lys703
of both monomers formed a projection on the same
orientation with DNA, and formed a suitable site for
covalent isopeptide bond between STAT1 and SUMO
(Figure 2B). Monomeric STAT1 molecules have a ten-
dency to form dimers in solution due to the β-sheet
structure between two C-tail segments of STAT1. The
formation of the β-sheet structure is mediated by hydro-
gen bonding through the backbone atoms of Glu705,
Ile707 and Val709. The formed dimer structure is
further stabilized by interactions in the hydrophobic
core between SH2 domains [3]. Substitution of Lys703
with Arg, a commonly used sumoylation abrogating
mutation, or substitution of Glu705 with Gln, are
not predicted to interfere phosphorylation of Tyr701
or interrupt interactions involved in the dimerization
interface, or directly affect DNA-binding properties of
STAT1 (Additional file 1: Figure S1 and Additional file 2:
Figure S2).
The crystal structure of thymine DNA glycosylase
(TDG) conjugated to SUMO-1 has revealed that TDG
forms two dissimilar molecular interfaces with SUMO-1.
The covalent contact to SUMO-1 occurs at the Lys330
residue, but another interface is a β-sheet structureformed by β-strands of TDG and SUMO-1 [25]. The
structure of STAT1 dimer (PDB code: 1bf5) has a linker
region (aa 684–699; loop structure) that is invisible in
the electron density maps [3]. The immediate vicinity of
sumoylation site to residues in both ‘ends’ of the loop
structure pointed us to investigate and remodel this
loop. To get insight on this, we constructed a model of
sumoylated STAT1 dimer using previously published
coordinates of conjugated SUMO-1 [25]. The loop
amino acids 684–699 was reconstructed using two pro-
grams Sybyl with Amber7 FF99 force field (Figure 2C)
and InsightII, and the analysis resulted in two highly
similar loop models. SUMO-1 was positioned on conju-
gation distance, and the constructed loop structure was
presented adjacent to β-sheet structure of SUMO-1.
This model proposes that interface between SUMO-1
and the loop structure of STAT1 can direct the SUMO-
1 moiety towards DNA, creating a steric hindrance that
can affect DNA-binding of sumoylated STAT1 dimer.
Sumoylation deficient STAT1 shows increased
DNA-binding activity
The molecular model suggested that sumoylation may
alter the DNA-binding properties of STAT1. Mutation
of Lys703 (K703R) or Glu705 (E705A) within the
sumoylation consensus sequence in STAT1 abolish
sumoylation of STAT1 and leads to enhanced STAT1
transcriptional activity [11,13]. Thus, we wanted to
investigate if the DNA-binding activity of sumoylation
deficient STAT1 mutants differ from the DNA-binding
properties of the WT STAT1. Amino acids essential to
SUMO conjugation reside in the close proximity of the
STAT1 activating Tyr701 phosphorylation site and
therefore the mutations in the sumoylation site may
affect to the tyrosine phosphorylation or dephosphoryla-
tion properties of STAT1. E705Q mutation in STAT1 is
predicted to have minimal structural consequences to
STAT1 but it abolishes STAT1 sumoylation (Additional
file 2: Figure S2) [17]. To analyse the phosphorylation of
different sumoylation deficient STAT1 mutants, U3A
cells lacking endogenous STAT1 were transfected either
with STAT1 WT or with sumoylation deficient K703R,
E705A or E705Q mutants. Phosphorylation deficient
STAT1 Y701F mutant was used as a negative control.
After IFN-γ stimulation cells were lysed and equal
amounts of protein were separated in SDS-PAGE and
Tyr701 phosphorylation was analyzed by using phospho-
Tyr701-STAT1 specific antibody (anti-pSTAT1, Rabbit
polyclonal antibody, Cell Signaling). The pSTAT1 anti-
body detected the Tyr701 phosphorylation of STAT1
E705Q, while the STAT1 E705A showed only a weak
signal and the antibody failed to detect IFN-γ stimulated
STAT1 K703R (Additional file 3: Figure S3A). The differ-
ence is likely to be caused by the altered amino acid
Figure 2 Ribbon diagram of the STAT1 homodimer-DNA complex (PDB code:1bf5) and model of SUMO conjugated STAT1 dimer.
(A) SUMO consensus element and amino acid (aa) sequence of SUMO-conjugation site in STAT1. The symbol ψ indicates large hydrophobic
amino acid and x can be any amino acid. (B) Coiled-coil domain, DNA-binding domain and linker region of one monomer are colored green and
the SH2 domain is colored in salmon red. SH2 domain of adjacent monomer is colored light yellow and other domains are blue. DNA strand is
labelled and colored in red. Residues, pTyr701 (salmon red), Lys703 (red) and Glu705 (blue) are shown in a stick representation. All ribbon
diagrams presented in Figure 2 are colored uniformly and produced using PyMOL (http://www.pymol.org). (C) The model of SUMO conjugated
STAT1 was constructed by superimposing the X-ray structures of SUMO-1 from the complex of SUMO-1-TDG (PDB code:1wyw) and the structure
of DNA bound STAT1 dimer (PDB code:1bf5). The molecular geometry of the loop 684–699 in the SH2 domain was calculated using the program
Sybyl with Amber 7 FF99 force field parameters. Green and blue colours were used to distinguish monomers in a ribbon diagram of DNA bound
STAT1 dimer. The loop and DNA are labeled and colored with red. The SUMO-1 was incorporated between the loop and DNA in conjugation
distance on both sides of dimer. SUMO-1 is represented in ribbon and its molecular surface in yellow. Graphics were produced using PyMOL
(http://www.pymol.org).
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the pSTAT1 antibody since another pSTAT1 antibody
(New England Biolabs) readily detected also K703R and
E705A mutants after pervanadate stimulation (data not
shown). The SUMO deficient STAT1 mutant E705Q
was chosen for further DNA-binding studies.
In order to study the DNA-binding properties of
STAT1, we performed oligoprecipitation experiments
using two biotinylated oligos, one containing STAT1-
binding site from Gbp-1 promoter and another withSTAT1-binding site from Irf-1 gene promoter. U3A cells
were transfected either with HA-tagged STAT1 WT or
STAT1 E705Q or STAT1 Y701F mutants together with
His-tagged SUMO-1. Cells were left unstimulated or
treated with IFN-γ and osmotic shock to induce STAT1
Tyr701 phosphorylation and STAT1 sumoylation, re-
spectively [12]. STAT1 WT and the STAT1 mutants
were oligoprecipitated from the whole cell lysates and
the phosphorylation of STAT1 was detected with anti-
pSTAT1 antibody. Sumoylation deficient STAT1 E705Q
Grönholm et al. BMC Biochemistry 2012, 13:20 Page 7 of 12
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to STAT1 WT (Figure 3A upper and the middle panel).
In the lysates the E705Q mutant was slightly less tyro-
sine phosphorylated than STAT1 WT (Figure 3A, lower
panel), indicating that the increased DNA-binding of
STAT1 E705Q is not a consequence of its altered
Tyr701 phosphorylation. Restaining the membranes
from Figure 3A with anti-HA antibody also showed that
more STAT1 E705Q was bound to DNA when com-
pared to STAT1 WT (Figure 3B). The result was verified
by quantitating the intensities of the oligoprecipitated
STAT1 bands that were normalized against total amount
of input STAT1 (detected with anti-HA antibody) or
against the amount of Tyr701 phosphorylated STAT1
(detected with anti-pSTAT1 antibody) (Additional file 3:
Figure S3B, C, D and E). Furthermore, overexpression of
SUMO-1 hindered STAT1 WT binding to Irf-1-oligo in
U3A cells, providing further proof that sumoylation
inhibits STAT1 DNA-binding (Additional file 3: Figure
S3F). Of note, additional oligoprecipitation experiments
were carried out with larger protein amounts that would
allow detection of sumoylated STAT1. In this experi-
mental setting, sumoylation was not detected in the
DNA-bound fraction of STAT1, while SUMO-1 conjuga-
tion was readily observed in equal amount of cellular
STAT1 (Additional file 3: Figure S3G). These results
suggest that sumoylated STAT1 does not bind to DNA
or that the DNA-binding of sumoylated STAT1 is sig-
nificantly diminished.
Promoter bound STAT1 dimer is known to inter-
act with histone acetyl transferase CREB-binding pro-
tein (CBP) and acetylation of histones is essential for
STAT1-mediated transcriptional activation [26]. Next,
we wanted to investigate whether the enhanced DNA-
binding of sumoylation deficient STAT1 has functional
consequences at the promoter level. To this end, we per-
formed chromatin immunoprecipitation (ChIP) assays
on the STAT1 target gene Gbp-1. U3A cells stably over-
expressing STAT1 WT or sumoylation deficient STAT1
mutant were either left unstimulated or stimulated with
human IFN-γ. Immunoprecipitation of cross-linked and
scattered chromatin was performed with anti-acetylated
histone H4 antibody or anti-rabbit IgG antibody as a
control. STAT1 K703R expressing cells showed increased
acetylation of histone H4 when compared to STAT1 WT
(Figure 3C). This result suggests that the enhanced pro-
moter binding of sumoylation defective STAT1 results in
enhanced association of histone acetyl transferases to the
promoter leading to increased histone H4 acetylation.
Sumoylation does not prevent STAT1 dimerization
Dimerization mediated through the interactions between
the Tyr701 phosphorylated tail segment of one STAT1
and the SH2 domain of an adjacent STAT1 is consideredto be essential for proper DNA-binding and transcrip-
tional activity of STAT1 [3]. To investigate if sumoylation
affects STAT1 dimerization and inhibits downstream
DNA-binding in this manner, cells were co-transfected
with HA- and Flag-tagged STAT1 together or without
His-tagged SUMO-1. After 48 hours, the cells were left
unstimulated or stimulated with IFN-γ and osmotic
shock prior to cell lysis. Equal amounts of whole cell
lysates were immunoprecipitated with anti-Flag agarose
beads and immunoblotting with anti-HA antibody was
used to detect if HA-tagged STAT1 molecules interact
with Flag-tagged STAT1. As shown in Figure 4A, a
slower migrating band (lanes 2 and 4) corresponding to
the size of SUMO-1 conjugated STAT1 was detected
with anti-HA antibody, suggesting that sumoylated HA-
tagged STAT1 interacts with STAT1-Flag. Figure 4B
shows as a control that anti-Flag agarose does not pull
down HA-tagged STAT1. These results suggest that
sumoylation of STAT1 does not prevent STAT1
dimerization and are consistent with the results that con-
jugated SUMO moiety affects the interaction between
STAT1 and DNA through steric hindrance.
Discussion
Sumoylation is a common post-translational modifica-
tion of transcription factors, but in several proteins the
physiological functions and molecular mechanisms of
this modification have remained enigmatic. Several lines
of evidence support the concept that SUMO serves as a
negative regulator of STAT1 [10,11,13,14]. Furthermore,
the results demonstrating that sumoylation also nega-
tively regulates STAT5-mediated signaling and the only
STAT transcription factor in Drosophila melanogaster,
Stat92E, indicates that sumoylation is an evolutionary
conserved post-translational modification for some
STAT transcription factors [18,19].
Sumoylation is a highly reversible covalent modifica-
tion that is regulated through conjugating and deconju-
gating enzymes. Several studies support the importance
of PIAS1-mediated sumoylation of the proteins. Recently,
it was shown that PIAS1 regulates oncogenic signaling
by sumoylating promyelocytic tumor suppressor (PML)
that leads to its ubiquitination and proteosomal degrad-
ation [27]. PIAS1 has also been shown to associate with
protein-tyrosine phosphatase 1B (PTP1B) and to catalyze
its sumoylation, which resulted in down-regulation of
the phosphatase activity and inhibited dephosphorylation
of the insulin receptor. PIAS1-mediated negative regula-
tion of PTP1B was reversed by SENP1, an isopeptidase
that was also shown to regulate sumoylation of STAT5
[18,28]. Senp1 knock out mice were found to have severe
defects in early T and B cell development. The defect in
lymphoid development was likely caused by enhanced
level of STAT5 sumoylation that subsequently led to
Figure 3 (See legend on next page.)
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Figure 3 Sumoylation deficient STAT1 mutant shows enhanced DNA-binding on STAT1 dependent promoters and enhanced histone
H4 acetylation at Gbp-1 promoter. (A) The binding of phosphorylated STAT1 WT, E705Q and Y701F to Gbp-1- and Irf-1-oligos. Plasmids
were transfected to U3A cells as indicated. Cells were either stimulated or left unstimulated with IFN-γ for 1h and osmotic shock (OS) for
15 minutes to induce STAT1 Tyr701 phosphorylation and STAT1 sumoylation, respectively. Equal amounts of total cell lysates were subjected
to oligoprecipitation with Gbp-1- and Irf-1-oligos following immunodetection with pSTAT1 antibody (upper and middle panel, respectively).
Tyr701 phosphorylated STAT1 WT and E705Q from the whole cell lysates (0.5% input) were blotted using anti-pSTAT1 antibody (lower panel).
(B) The Western blot membranes from 3A were stripped and reprobed with anti-HA antibody to detect DNA bound STAT1 and the expression
level of STAT1s in the lysates. (C) Sumoylation defective STAT1 K703R shows enhanced acetylation of histone H4 at the IFN-γ-dependent Gbp-1
promoter. Stably transfected STAT1 WT and STAT1 K703R U3A clones were starved overnight and stimulated as indicated. Immunoprecipitation of
cross-linked chromatin was performed with anti-acetyl H4 antibody and anti rabbit IgG as a control antibody. DNA was extracted and analysed
by qPCR using primers specific for IFN-γ inducible Gbp-1 promoter sequence. The values from immunoprecipitation were normalized to the total
input DNA. The mean qPCR values ± SD from three independent experiments are shown. IB: immunoblot, IP: immunoprecipitation, OP:
oligoprecipitation, OS: osmotic shock.
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experiments removal of conjugated SUMO-1 by SENP1
increased STAT1-mediated reporter gene expression,
thus confirming the negative regulatory role of sumoyla-
tion for STAT1 (Figure 1B).
STAT1 homodimerization is required for the optimal
IFN-γ-mediated gene activation and STAT1 homodimers
form a nutcracker-like structure that binds to DNA. The
monomers are held together by interface between
Tyr701 phosphorylated C-terminal tail segment of one
monomer and the SH2 domain of the other [3]. The
Lys703 is located adjacent to the dimerization interface
and this prompted us to investigate if sumoylation of the
Lys703 could affect dimerization or DNA-binding of
STAT1. Analysis of the SUMO conjugation consensus
site in STAT1 dimer revealed that side chain of Lys703
formed a projection towards DNA. Both Lys703 and
Glu705 residues have hydrophilic side chains, which are
converted away from the hydrophobic core of SH2 inter-
face. Additionally, the β-sheet structure between two C-
tail segments of STAT1 dimer is not likely to be affected
by Lys703 mutation to Arg, while this mutation will
interrupt the formation of covalent bond with SUMO.
The structural analysis revealed that side chain of
Lys703 has an interaction phase with Glu632 residue in
the SH2 domain of the adjacent monomer. Most prob-
ably this interface prevents rotation of this flexible side
chain and keeps orientation favorable for the SUMO
conjugation. The finding of controlled position of
Lys703 also supports the importance of Lys703 as an
SUMO acceptor site (Additional file 2: Figure S2).
Sumoylation has been shown to impede Tyr701 phos-
phorylation of STAT1 and subsequent SH2 domain-
phospho-Tyr701-mediated homodimerization, leading to
formation of semi-phosphorylated dimers that interact
through their N-terminal domains [15-17]. Our experi-
mental data indicated that sumoylated STAT1 can form
dimers, but it remains to be determined if the inter-
action is mediated through their N-terminal domains or
through the SH2 domains (Figure 4).To predict how SUMO-1 would structurally orientate
in SH2 domain-phospho-Tyr701 interaction-mediated
STAT1 dimers, we reconstructed the structure of the
disordered loop 684–699 of STAT1, and made a molecu-
lar model of sumoylated STAT1 dimer using x-ray struc-
ture of TDG-SUMO-1 as a template [25]. This model
suggests that the position of SUMO under the loop
structure is directed towards DNA and can inhibit inter-
action with nucleic acids (Figure 2C). Furthermore,
results from the oligonucleotide pull down experiments
indicated that sumoylation interferes STAT1 binding to
STAT1-responsive promoters, as sumoylation deficient
STAT1 E705Q showed increased DNA-binding to both
Gbp-1- and Irf-1-oligos (Figure 3A and B), and as
SUMO-1 overexpression hindered STAT1 binding to Irf-
1-oligo (Additional file 3: Figure 3F). The difference in
the DNA-binding properties between STAT1 WT and
E705Q mutant was not caused by altered Tyr701 phos-
phorylation (Figure 3A and B) [15-17]. In addition,
another sumoylation deficient STAT1 mutant K703R
also showed increased binding to Gbp-1 oligo (data not
shown). Taken together, the oligoprecipation experi-
ments are supporting the molecular model where
SUMO moiety interferes with DNA-binding of STAT1
(Figure 3A and B, Additional file 3: Figure S3F).
Sumoylated STAT1 was not detected in our oligopreci-
pitation experiments (Additional file 3: Figure S3G) and
this result is consistent with results by Song et al.
(2006), showing that sumoylated STAT1 does not bind
to DNA, or that the bound fraction is very small [29].
In their EMSA studies Song et al. also found that
sumoylation deficient STAT1 K703R mutant shows pro-
longed binding to GAS-probe, but unexpectedly sumoy-
lation deficient E705A mutant had similar DNA-binding
profile than STAT1 WT [29]. We chose to use STAT1
E705Q mutant in the DNA-binding experiments because
the mutant has been reported to have minimal SUMO-
independent effects on STAT1 when compared to K703R
and E705A mutations [17]. Our results with STAT1
E705Q suggest that sumoylation inhibits DNA-binding
Figure 4 Sumoylation does not prevent dimerization of STAT1. (A) Sumoylated STAT1 can participate in STAT1 dimers. Cos-7 cells were
transiently transfected with STAT1-Flag, STAT1-HA and SUMO-1-His as indicated. 48 hours after transfection cells were either treated or left
untreated with 100 ng/ml of human IFN-γ for 45 min and with 0.3 M sorbitol for osmotic shock for 15 min followed by cell lysis. Equal amounts
of cell lysates were subjected to co-immunoprecipitation with anti-Flag agarose beads followed immunodetection with anti-HA antibody to
reveal STAT1-Flag interacting STAT1-HA proteins. Equal amounts of whole cell lysates (1% input) were separated on the same SDS-PAGE gel and
immunoblotted with anti-HA (right panel). Longer exposure time was needed to reveal STAT1-sumoylation bands in the inputs. (B) Control
experiment showing that anti-Flag agarose does not bind directly to HA-tagged STAT1. Cos-7 cells were transfected, stimulated and
immunoprecipitated as described above. IB: immunoblot, IP: immunoprecipitation, OS: osmotic shock.
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published results of Song et al. (2006), we observed that
STAT1 K703R has enhanced binding to Gbp-1-oligo
when compared to STAT1 WT as well (data not shown).
Furthermore, sumoylation deficient STAT1 showed
enhanced histone H4 acetylation on Gbp-1 promoter
(Figure 3C), thus functionally confirming the enhanced
STAT1 promoter binding. Whether sumoylation also
alters the interaction with histone acetyl transferases,
such as CBP, remains to be determined.
It has become evident that sumoylation participates in
regulation of STATs and the precise molecular mechan-
isms and physiological functions are gradually being
revealed. Several studies have analysed sumoylation in
STAT1, and sumoylation has been shown to inhibit
STAT1 activity by different mechanisms. SUMO conju-
gation to Lys703 inhibits phosphorylation of Tyr701
[15,16] and prevents paracrystal formation, thereby
increasing solubility of STAT1 which subjects STAT1
for dephosphorylation [14,17]. Our results suggest an
additional regulatory mechanism for sumoylation andindicate that SUMO moiety is directed towards DNA
and can inhibit DNA-binding of STAT1.
Conclusions
SUMO conjugation to STAT1 has been shown to nega-
tively regulate STAT1-mediated gene responses [11,13,14].
This study was aimed to investigate further the mechan-
ism by which sumoylation regulates STAT1. The inhibi-
tory role of SUMO-1 on STAT1 was confirmed by
showing that overexpression of desumoylating enzyme
SENP1 increases STAT1-mediated transcriptional activ-
ity. A molecular model of sumoylated STAT1 dimer sug-
gested that SUMO-1 is directed towards DNA creating
steric hindrance that is able to affect DNA-binding prop-
erties of STAT1. Oligoprecipitation experiments were
consistent with this model and showed that sumoylation
deficient STAT1 mutant has enhanced binding to two
independent STAT1 target gene promoters. The differ-
ence in DNA-binding was not attributed to the level of
Tyr701 phosphorylation of STAT1. Consequently, sumoy-
lation defective STAT1 mutant displayed increased histone
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findings suggest that sumoylation functions as a negative
regulator of STAT1 responses by modulating the DNA-
binding properties of STAT1.
Additional files
Additional file 1: Stick presentation of antiparallel β-sheet structure
of the STAT1 dimer interface. C-terminal tails of adjacent monomers in
STAT1 dimer interface and other residues forming interactions with C-tail
residues are coloured with light yellow (monomer 1) and salmon red
(monomer 2).Glu705 is coloured with blue and Lys703 with red. β-sheet
hydrogen bonding formed between C-terminal tails of monomers and
pTyr701 interactions with adjacent SH2 domain are indicated with
dashed lines. DNA has been represented as a stick model under the
monomer interface and coloured with light blue.
Additional file 2: Orientation of Lys703Arg and Glu705Gln mutated
amino acids in STAT1 structure. Details of the residues 701–705 in the
C-terminal tail segment and SUMO consensus site of one monomer are
shown in stick (backbone) and stick and ball (side chains) representation
(green colour). Adjacent SH2 domain is showed in ribbon, except the
interaction forming side chain of Glu632 is shown in stick and ball
representation (yellow colour). Side chains of mutated Gln705 and
Arg703 (purple colour) are shown together with side chains of WT
Glu705 and Lys703. Labels have the same colour as the residues they
indicate. Thr704 and Glu632 residues are also indicated with arrows.
Hydrogen atoms (H) are coloured in light grey, oxygen atoms (O) in red
and nitrogen atoms (N) in blue.
Additional file 3: Analysis of the Tyr701 phosphorylation of the
sumoylation deficient STAT1 mutants and the effect of sumoylation
on STAT1 DNA-binding. (A) Tyr701 phosphorylation of WT STAT1 and
STAT1 mutants in response to IFN-γ. U3A cells were transfected with
STAT1 WT, K703R, E705A, E705Q or Y701F together with SUMO-1-His as
indicated. Cells were either left unstimulated or stimulated with IFN-γ
prior to lysis. Equal amounts of protein lysates were separated in
SDS-PAGE and immunoblotted with anti-pSTAT1 and anti-HA antibodies.
(B, C) Comparison of band intensities of the Gbp-1-oligoprecipitated WT
STAT1 and STAT1 E705Q stained with anti-pSTAT1 (B) and anti-HA (C)
antibodies. (D, E) Comparison of WT STAT1 and STAT1 E705Q band
intensities from to Irf-1-oligoprecipitates stained with anti-pSTAT1 (D) and
anti-HA (E) antibodies. Band intensities were studied with ImageJ
software and analysed after background subtraction. The intensity of WT
STAT1 was set as one in every bar graph (B-E). The error bars indicate SD
from two independent experiments. (F) Overexpression of SUMO-1
inhibits STAT1 DNA-binding. U3A cells were transfected with STAT1-HA
together with empty vector or SUMO-1-His. Cells were stimulated with
IFN-γ and osmotic shock as indicated. After cell lysis equal amounts of
protein from the whole cell lysates were oligoprecipitated with
Irf-1-oligo and separated in SDS-PAGE followed by immunoblotting with
anti-pSTAT1 antibody (upper panel). For detection of the total amount of
Tyr701 phosphorylated STAT1 and the STAT1 expression levels in the
lysates, equal amounts of protein lysates were immunoblotted with
anti-pSTAT1 and anti-HA antibodies, respectively (middle and the lower
panel). (G) Sumoylated STAT1 does not bind DNA. Cos-7 cells were
transfected with WT STAT1-HA together with SUMO-1-His. Prior to lysis
cells were stimulated with IFN-γ and osmotic shock as indicated.
Gbp-1-oligoprecipitated proteins were separated in the SDS-PAGE
together with protein samples from the whole cell lysates (10% input).
STAT1 and STAT1-SUMO-1 bands were detected by immunoblotting with
anti-HA antibody. Both panels are from the same gel, but additional
lanes have been cut off from the middle. IB: immunoblot, OP:
oligoprecipitation, u.s.: unspecific band.
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